M. Rosenstein

发表

The systemic administration of purified interleukin 2 enhances the ability of sensitized murine lymphocytes to cure a disseminated syngeneic lymphoma.

A. Chang, S. Rosenberg, M. Lotze, 1984, Journal of immunology.

Generation of lytic and proliferative lymphoid clones to syngeneic tumor: in vitro and in vivo studies.

S. Rosenberg, M. Rosenstein, 1984, Journal of the National Cancer Institute.

Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.

S. Rosenberg, I. Yron, M. Rosenstein, 1984, Cancer research.

In vitro growth of murine T cells. VI. Accelerated skin graft rejection caused by adoptively transferred cells expanded in T cell growth factor.

T. Eberlein, S. Rosenberg, P. Sugarbaker, 1981, Journal of immunology.

Lymphocyte subpopulations, serum IgE and total eosinophil counts in patients with bronchial asthma.

S. Gupta, M. Grieco, R. Frenkel, 1975, Clinical and experimental immunology.

Lysis of fresh natural killer-resistant tumor cells by lectin-activated syngeneic and allogeneic murine splenocytes.

S. Rosenberg, A. Mazumder, M. Rosenstein, 1983, Cancer research.

Interferon adjuvant therapy of melanoma

J. Kirkwood, D. Wazer, M. Rosenstein, 1997, Cancer.

Adoptive immunotherapy of a syngeneic murine leukemia with a tumor-specific cytotoxic T cell clone and recombinant human interleukin 2: correlation with clonal IL 2 receptor expression.

S. Rosenberg, L. Matis, A. Kruisbeek, 1986, Journal of immunology.

Eradication of a disseminated syngeneic mouse lymphoma by systemic adoptive transfer of immune lymphocytes and its dependence upon a host component(s).

S. Rosenberg, J. Mulé, S. Shu, 1985, Cancer research.

Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin 2.

S. Rosenberg, S. Ettinghausen, M. Rosenstein, 1986, Journal of immunology.

Retention of adoptively transferred interleukin-2-activated natural killer cells in tumor tissue.

M. Posner, R. Goldfarb, A. Safatle-Ribeiro, 1997, Anticancer research.

Generation of long-term T-lymphoid cell lines with specific cytotoxic reactivity for a syngeneic murine lymphoma.

T. Eberlein, S. Rosenberg, P. Spiess, 1982, Journal of the National Cancer Institute.

Optimal methods for generating expanded lymphokine activated killer cells capable of reducing established murine tumors in vivo.

S. Rosenberg, R. Lafrenière, M. Rosenstein, 1986, Journal of immunological methods.

Simplified techniques for the isolation of alloreactive cell lines and clones with specific cytotoxic or proliferative activity.

T. Eberlein, S. Rosenberg, S. Schwarz, 1983, Journal of immunological methods.

In vivo administration of purified Jurkat-derived interleukin 2 in mice.

E. Jaffe, R. Braziel, S. Rosenberg, 1984, Cancer research.

Development of long-term cell lines and lymphoid clones reactive against murine and human tumors: a new approach to the adoptive immunotherapy of cancer.

T. Eberlein, S. Rosenberg, M. Lotze, 1982, Surgery.